Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer
1996

Loss of Antigen-Presenting Molecules in Lung Cancer

Sample size: 93 publication Evidence: moderate

Author Information

Author(s): P Korkolopoulou, L Kaklamanis, F Pezzella, AL Harris, KC Gatter

Primary Institution: University of Oxford

Hypothesis

The study investigates the expression of MHC class I antigens and TAP-1 protein in non-small-cell lung carcinomas and their relationship with clinico-pathological data.

Conclusion

Loss of antigen-presenting molecules is common in lung cancer, but their expression does not correlate with tumor characteristics or patient survival.

Supporting Evidence

  • 38% of cases showed total loss of MHC class I molecules.
  • Selective loss of A locus was seen in 8.3% of cases.
  • 27% of cases exhibited selective loss of the A2 allele.
  • TAP-1 loss was always associated with loss of beta2-microglobulin and/or heavy chain.

Takeaway

In lung cancer, important molecules that help the immune system recognize tumors are often missing, but this doesn't seem to affect how the cancer grows or how long patients live.

Methodology

The study analyzed 93 resection specimens of non-small-cell lung carcinomas using immunohistochemical methods to assess the presence of MHC class I antigens and TAP-1.

Limitations

The study did not find a correlation between the expression of MHC class I and TAP-1 and various tumor characteristics or patient survival.

Participant Demographics

The study included 93 patients, with 73 men and 20 women, having a mean age of 60.3 years.

Statistical Information

P-Value

>0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication